UltraLinq, a company specialising in digital healthcare solutions, launched a new cardiac monitoring product at the Arab Health exhibition. The product will use advanced technology to provide improved monitoring and diagnosis of heart conditions for patients. The launch of this product is part of UltraLinq's efforts to promote digital transformation in healthcare.
Jordan Wittmeier, Head of Commercial & Operations, said: “With thousands of industry players all under one roof over four days, Arab Health is the ideal event to showcase our latest innovation. We look forward to meeting key stakeholders and potential distributors to discuss how our revolutionary end-to-end patient monitoring concept can transform the way cardiac arrhythmias are diagnosed for patients, while enabling hospitals to expand their services, saving both time and costs. This new service will enable improved arrhythmia identification and appropriate management of patients with AF which could save the high cost of long-term care of stroke survivors.”
Read the full aricle by Med-Tech News here: med-technews.com